Given the established involvement of PAK signalling in angiogenesis and immune regulation [14], we have further determined the effects of PAK1 and PAK4 on tumour vasculature in PDA, and their impact on therapeutic outcomes. This evidence concerns the gene PAK4 and neoplasm.